A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.
Two monoclonal antibody targeted therapies have been recommended for routine NHS use in England by the National Institute for Health and Care Excellence (NICE). Spesolimab (Spevigo, Boehringer ...
A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results